TherapeuticsMD's total assets for Q1 2026 were $37.58M, a decrease of -0.20% from the previous quarter. TXMD total liabilities were $10.61M for the fiscal quarter, a -1.60% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.